Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative Evaluation of Comprehensive DNA and RNA Sequencing Platforms with Subsequent Clinical Validation for Hematolymphoid Malignancies.

Cancers·2026

Same author

Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup: Insights from 200 Cases following Deployment as a First-Line Diagnostic Test in a Tertiary Care Center.

The Journal of molecular diagnostics : JMD·2026

Same author

Speed meets precision: rapid intraoperative diagnostics in neuro-oncologic surgery.

Trends in cancer·2026

Same author

CDKN2A Chromogenic In Situ Hybridization for Separating Benign From Malignant Mesothelial Proliferations.

The American journal of surgical pathology·2025

Same author

Integrative cytogenetic and molecular studies unmask "chromosomal mimicry" in hematologic malignancies.

Blood advances·2025

Same author

Multisite Evaluation and Validation of Optical Genome Mapping for Prenatal Genetic Testing.

The Journal of molecular diagnostics : JMD·2024

Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026

Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026

Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026

Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026

Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026

Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Copy Number Analysis in Cancer Diagnostic Testing.

Tara Spence¹, Adrian M Dubuc²

¹Cytogenomics Laboratory, Vancouver General Hospital, Jim Pattison South, 899 12th Avenue West, Vancouver, British Columbia, V5Z 1M9, Canada.

Clinics in Laboratory Medicine

|September 23, 2022

Summary

This summary is machine-generated.

Accurate copy number alteration (CNA) detection is vital for cancer care. This review covers classic, emerging, and future technologies for CNA detection in oncology, highlighting their benefits and limitations.

Keywords:

Clinical oncology Copy number analysis Cytogenomics Genome diagnostics

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Experiment Videos

Last Updated: Aug 27, 2025

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

Oncology
Genetics
Molecular Biology

Background:

Accurate detection of copy number alterations (CNAs) is crucial for cancer diagnosis, prognosis, and treatment.
Traditional cytogenetic methods like karyotyping, FISH, and chromosomal microarray are standard in clinical labs.
Advancements in next-generation sequencing and optical genome mapping are revolutionizing CNA detection.

Purpose of the Study:

To review the benefits and limitations of current and future technologies for detecting CNAs in oncology.
To provide an overview of classic, emerging, and projected cytogenomic and molecular oncology tools.
To guide the clinical application of CNA detection technologies.

Main Methods:

Review of existing literature on cytogenetic and molecular techniques for CNA detection.
Analysis of the advantages and disadvantages of various CNA detection methods.
Discussion of the clinical utility and future prospects of cytogenomic technologies.

Main Results:

Classic methods offer established reliability but may lack resolution.
Emerging technologies like next-generation sequencing and optical genome mapping provide higher accuracy and cost-effectiveness.
Future technologies promise further improvements in CNA detection sensitivity and clinical integration.

Conclusions:

A new era of cytogenomics and molecular oncology is emerging, driven by technological advancements.
The choice of CNA detection technology depends on clinical context, balancing accuracy, cost, and throughput.
Integrating novel technologies into routine clinical practice will enhance cancer patient management.